Webinar: Drug Discovery Powered by HUB Organoids and OcellO 3D Image Analysis

Drug Discovery Powered by HUB Organoids and OcellO 3D Image Analysis

Summary:
More clinically relevant models are urgently needed for preclinical drug development. This webinar discusses the development and characterization of HUB Organoid models, and how these are applied to OcellO’s screening platform to offer services to study and advance therapeutics for oncology, and immuno-oncology. The speakers describe HUB Organoid features that preserve the genetic and phenotypic characteristics of the original tumor, and provide insight into the unique high-throughput, high content imaging-based in vitro system for screening the efficacy of (immuno)oncological drugs and exemplify the use of the system to prioritize cancer drug candidates to enter the clinic.

Learning Objectives:

  • Features and advantages of HUB Organoids™
  • Why HUB Organoids are considered to be superior 3D preclinical model systems
  • How to apply HUB Organoids to fundamental research and infectious diseases
  • Impact and possibilities of HUB Organoids in oncology and immuno-oncology drug discovery
  • OcellO’s 3D in vitro screening platform – value of combining 3D in vitro systems with high-throughput and high-content analysis
  • How the use of OcellO 3D in vitro oncology assay and HUB CRC Organoids can advance preclinical candidates to the clinic
  • How OcellO’s immuno-oncology assay is changing the possibilities of preclinical translation of immunotherapies

Who Should Attend:

  • Drug developers interested in understanding the benefit of (tumor) organoids compared to standard 3D systems
  • Decision makers from biotech and pharmaceutical companies who are looking to enhance the translatability of their early stage drug development programs
  • Researchers interested in learning about HUB Organoids and their predictive power
  • Biotech and pharma companies interested in high-throughput, high content imaging-based in vitro system for screening the efficacy of (immuno)oncological drugs

Speakers: Robert Vries (HUB), Bram Herpes (OcellO) and Lidia Daszkiewicz (Ocello)

Date: Monday, October 26

Time: 11AM EDT

Register now: Drug Discovery Powered by HUB Organoids and OcellO 3D Image Analysis

November 04, 2020 3 Days of 3D Cell Model Virtual Event 2020 Get ready for 3 days of 3D As organoids, spheroids and the study of 3D cell culture models continue to show their potent... read more
September 04, 2020 HUB and BGI-Qingdao sign a Memorandum of Unde... Utrecht and Qingdao, Sep 4th, 2020 – Hubrecht Organoid Technology (HUB) and BGI-Qingdao announced today that they ... read more
May 27, 2020 Studying the development of ovarian cancer wi... read more